A complete application in a minute
Tailored resume and cover letter, ready to send.
Sarah Cannon Research Institute (SCRI), a McKesson subsidiary, is advancing oncology research through digital transformation and AI-enabled solutions. The Product Analyst bridges business needs and IT, guiding data-driven initiatives within SCRI Development Innovations, delivering measurable outcomes.
The role emphasizes hands-on delivery, rapid experimentation, and collaboration with leaders and delivery teams.
It’s More Than a Career, It’s a Mission. Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe.
We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission & People who live with cancer - those who work to prevent it, fight it, and survive it - are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
The Product Analyst – Digital Transformation advances SCRI's digital strategy by translating business needs into practical technology solutions. Serving as a bridge between business and IT teams, this role supports process improvement, data integrity, and AI-enabled transformation within SCRI Development Innovations. The position emphasizes hands-on delivery, rapid experimentation, and measurable business outcomes. This is a remote position based in the US: relocation assistance and visa sponsorship are not available.
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.
Please click here to learn more about our research offerings. We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered. For more information regarding benefits through our parent company, McKesson, please click here.
By providing your personal information here, you are acknowledging our privacy statement. (English) http://www.mckesson.com/about-mckesson/privacy-notice-careers-EN/ For information on how we use cookies and other tracking technologies on our website, see our Cookie Notice. http://www.mckesson.com/about-mckesson/cookie-notice/